Working with Patient Groups

Home
Partnerships
Patient groups

Working with patient groups

To help patients get the most from our medicines, we share knowledge on the latest advancements in healthcare with a number of patient organisations and health charities, across a variety of activities and disease areas. Providing patient representative bodies with up-to-date and accurate information about our treatments is one of our core responsibilities.

By focusing our efforts on areas of unmet need, together we are addressing the challenges that prevent patients from receiving fast, equitable access to innovative healthcare solutions that are centred on early diagnosis and preventing disease progression.

CLL (Chronic Lymphocytic Leukaemia) Support is one of the UK’s largest patient-led charities. We deliberately focus our pharmaceutical collaborations on those providing treatments or research in CLL. AstraZeneca have been a long-time partner with collaborations in research, patient perspectives, CLL community education through to creating podcasts, videos and advising on patient advisory boards. We see the collaboration as a win-win for all

Marc Auckland

CLLSA Chair of Trustees

Being able to partner with AstraZeneca has allowed Kidney Care UK to raise significant awareness about chronic kidney disease (CKD) and drive engagement with different audiences who would otherwise struggle to engage with their medical risk factors around CKD